KRKA DD NPV revenue for the last year amounted to 1.81 B EUR, the most of which — 1.47 B EUR — came from its highest performing source at the moment, Prescription Pharmaceuticals, the year earlier bringing 1.39 B EUR. The greatest contribution to the revenue figure was made by Other — last year it brought KRKA DD NPV 718.00 M EUR, and the year before that — 635.10 M EUR.